Skip to main content

Table 1 Baseline demographics and clinical characteristics for participants

From: Genetic diversity in L1 ORF of human papillomavirus in women with cervical cancer with and without human immunodeficiency virus in Botswana and Kenya

 

Total n = 98

HR-HPV

n = 82

LR-HPV

n = 16

P-value

Median Age in years Median (IQR)

50 (42–54)

50 (42–61)

51.5 (47.5–57)

0.67a

Country, n (%)

    

 Botswana

72 (73.5)

66 (80.5)

6 (37.5)

 < 0.001b

 Kenya

26 (26.5)

16 (19.5)

10 (62.5)

 

HIV status, n (%)

n = 72

n = 66

n = 6

 

 HIV negative

31 (43.1)

27 (40.9)

4 (66.7)

 

 HIV positive

41 (56.9)

39 (59.1)

2 (33.3)

0.22b

Cancer stage, n (%)**

n = 43

n = 39

n = 4

 

 Stage 1

6 (14.0)

6 (15.4)

0 (0.0)

0.69b

 Stage 2

21 (48.8)

18(46.2)

3 (75.0)

 

 Stage 3

15 (34.9)

14 (35.9)

1 (25.0)

 

 Stage 4

1 (2.3)

1 (2.6)

0 (0.0)

 
  1. HIV human immunodeficiency virus, HPV human papillomavirus, HR high risk, LR low risk, IQR interquartile range
  2. aP-value was calculated using the Rank sum test
  3. bP-values were obtained by chi-square test
  4. **Cancer stage was only available for Botswana data